{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:28:23Z","timestamp":1792596503374,"version":"4.5.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander Foundation","doi-asserted-by":"publisher","award":["2018.101.1"],"award-info":[{"award-number":["2018.101.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["C01"],"award-info":[{"award-number":["C01"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1530"],"award-info":[{"award-number":["SFB1530"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["KU1315\/14-1"],"award-info":[{"award-number":["KU1315\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70112112"],"award-info":[{"award-number":["70112112"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.molmed.2024.10.004","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:19:27Z","timestamp":1729585167000},"page":"326-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Advances in Hodgkin lymphoma research"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-7191","authenticated-orcid":false,"given":"Ralf","family":"K\u00fcppers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.10.004_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/095952873201700106","article-title":"On some morbid appearances of the absorbent glands and spleen","volume":"17","author":"Hodgkin","year":"1832","journal-title":"Med. Chir. Trans."},{"key":"10.1016\/j.molmed.2024.10.004_bb0010","first-page":"133","article-title":"On the pathological changes in Hodgkin\u2019s disease with special reference to its relation to tuberculosis","volume":"10","author":"Reed","year":"1902","journal-title":"Johns Hopkins Hosp. Rep."},{"key":"10.1016\/j.molmed.2024.10.004_bb0015","first-page":"21","article-title":"\u00dcber eine eigenartige unter dem Bilde der Pseudoleuk\u00e4mie verlaufende Tuberkolose des lymphatischen Apparates","volume":"19","author":"Sternberg","year":"1898","journal-title":"Z. Heilkd."},{"key":"10.1016\/j.molmed.2024.10.004_bb0020","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2024.10.004_bb0025","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0035","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed\u2013Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"K\u00fcppers","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.10.004_bb0040","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1002\/j.1460-2075.1993.tb06189.x","article-title":"Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections","volume":"12","author":"K\u00fcppers","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.10.004_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/1357-4310(95)80016-6","article-title":"Molecular single-cell analysis of Hodgkin and Reed\u2013Sternberg cells","volume":"1","author":"K\u00fcppers","year":"1995","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.molmed.2024.10.004_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ijc.2910570607","article-title":"Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed\u2013Sternberg cells","volume":"57","author":"Roth","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2141.1996.d01-1780.x","article-title":"Phenotype, genotype and clonality of Reed\u2013Sternberg cells in nodular sclerosis Hodgkin\u2019s disease: results of a single-cell study","volume":"94","author":"Delabie","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0060","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199510053331403","article-title":"Hodgkin\u2019s disease with monoclonal and polyclonal populations of Reed\u2013Sternberg cells","volume":"333","author":"Hummel","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0065","first-page":"1644","article-title":"Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin\u2019s lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin\u2019s lymphoma","volume":"63","author":"Br\u00e4uninger","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0070","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1073\/pnas.95.17.10117","article-title":"Isolation of viable Hodgkin and Reed\u2013Sternberg cells from Hodgkin disease tissues","volume":"95","author":"Irsch","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.10.004_bb0075","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed\u2013Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0080","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and Reed\u2013Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM199602083340615","article-title":"Immunoglobulin V genes in Reed\u2013Sternberg cells","volume":"334","author":"K\u00fcppers","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0090","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood.V92.8.2899","article-title":"Detection of clonal Hodgkin and Reed\u2013Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin\u2019s disease","volume":"92","author":"Vockerodt","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/labinvest.3780237","article-title":"Molecular single-cell analysis of Hodgkin- and Reed\u2013Sternberg cells harboring unmutated immunoglobulin variable region genes","volume":"81","author":"M\u00fcschen","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.molmed.2024.10.004_bb0100","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed\u2013Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.10.004_bb0105","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","article-title":"Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas","volume":"106","author":"Bechtel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0110","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/342929a0","article-title":"Mechanism of antigen-driven selection in germinal centres","volume":"342","author":"Liu","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.004_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin\u2019s disease","volume":"16","author":"K\u00fcppers","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0120","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1172\/JCI95993","article-title":"Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells","volume":"128","author":"Weniger","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.10.004_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classical Hodgkin\u2019s disease as a T cell lymphoma","volume":"191","author":"M\u00fcschen","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0130","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed\u2013Sternberg cells of classic Hodgkin disease","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.LAB.0000027839.98023.5A","article-title":"T-cell variant of classical Hodgkin\u2019s lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction","volume":"82","author":"Willenbrock","year":"2002","journal-title":"Lab. Investig."},{"key":"10.1016\/j.molmed.2024.10.004_bb0140","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/bjh.19442","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative","volume":"204","author":"Ganapathi","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0145","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/jnci\/84.23.1789","article-title":"Chromosomal abnormalities in patients with Hodgkin\u2019s disease: evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed\u2013Sternberg cells","volume":"84","author":"Poppema","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2024.10.004_bb0150","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V86.4.1464.bloodjournal8641464","article-title":"Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed\u2013Sternberg cells in 100% of analyzed cases of Hodgkin\u2019s disease","volume":"86","author":"Weber-Matthiesen","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0155","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1158\/0008-5472.CAN-06-1992","article-title":"Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed\u2013Sternberg cells of classical Hodgkin lymphoma","volume":"66","author":"Martin-Subero","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0160","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V94.9.3129","article-title":"Overexpression of I kappa B alpha without inhibition of NF-\u03baB activity and mutations in the I kappa B alpha gene in Reed\u2013Sternberg cells","volume":"94","author":"Emmerich","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkBa gene in the malignant cells in Hodgkin\u2019s disease","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed\u2013Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.004_bb0180","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/gcc.20789","article-title":"Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma","volume":"49","author":"Schmidt","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2141.2012.09113.x","article-title":"Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma","volume":"157","author":"Otto","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0195","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed\u2013Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0200","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","article-title":"Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2","volume":"99","author":"Joos","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0205","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-09-3843","article-title":"Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma","volume":"108","author":"Martin-Subero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0215","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2024.10.004_bb0220","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.10.004_bb0225","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0230","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0235","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","article-title":"Detection of genomic imbalances in microdissected Hodgkin and Reed\u2013Sternberg cells of classical Hodgkin\u2019s lymphoma by array-based comparative genomic hybridization","volume":"93","author":"Hartmann","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":"Cooperative epigenetic modulation by cancer amplicon genes","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2024.10.004_bb0245","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.004_bb0250","first-page":"37","article-title":"Absence of HLA class I expression by Reed\u2013Sternberg cells","volume":"145","author":"Poppema","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0255","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0260","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow-sorting and exome sequencing reveals the oncogenome of primary Hodgkin and Reed\u2013Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0265","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.seminhematol.2016.05.011","article-title":"Novel agents in the treatment of Hodgkin lymphoma: biological basis and clinical results","volume":"53","author":"Younes","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0275","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/gcc.22276","article-title":"Alterations of the CD58 gene in classical Hodgkin lymphoma","volume":"54","author":"Schneider","year":"2015","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/gene.2016.30","article-title":"CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse","volume":"17","author":"Abdul Razak","year":"2016","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2024.10.004_bb0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/gcc.22331","article-title":"Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma","volume":"55","author":"Salipante","year":"2016","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0295","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.10.004_bb0300","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0305","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ijc.1438","article-title":"TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein\u2013Barr virus","volume":"94","author":"Maggio","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9440(10)63795-9","article-title":"Low frequency of FAS mutations in Reed\u2013Sternberg cells of Hodgkin\u2019s lymphoma","volume":"162","author":"Maggio","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0315","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V94.5.1755","article-title":"Mutation of the p53 gene is not a typical feature of Hodgkin and Reed\u2013Sternberg cells in Hodgkin\u2019s disease","volume":"94","author":"Montesinos-Rongen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0320","first-page":"5640","article-title":"Somatic mutations of the CD95 gene in Hodgkin and Reed\u2013Sternberg cells","volume":"60","author":"M\u00fcschen","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0325","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1038\/s41467-023-41954-8","article-title":"Transcriptional reprogramming by mutated IRF4 in lymphoma","volume":"14","author":"Schleussner","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.10.004_bb0330","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK\u2013STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0335","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin\u2019s lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0340","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed\u2013Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.molmed.2024.10.004_bb0345","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","article-title":"Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells","volume":"4","author":"Maura","year":"2023","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.molmed.2024.10.004_bb0350","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.004_bb0355","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-invasive detection of genomic imbalances in Hodgkin\/Reed\u2013Sternberg cells in early and advanced stage Hodgkin\u2019s lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0360","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-023-06903-x","article-title":"Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling","volume":"625","author":"Alig","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.004_bb0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0370","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.medj.2021.09.002","article-title":"In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin\u2019s lymphoma and facilitates ultrasensitive residual disease detection","volume":"2","author":"Sobesky","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.molmed.2024.10.004_bb0375","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0380","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1158\/2767-9764.CRC-23-0140","article-title":"Ultra-deep sequencing reveals the mutational landscape of classical Hodgkin lymphoma","volume":"3","author":"Gomez","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.molmed.2024.10.004_bb0385","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2643-3230.BCD-20-0203","article-title":"Dissecting clonal hematopoiesis in tissues of patients with classic Hodgkin lymphoma","volume":"2","author":"Venanzi","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.molmed.2024.10.004_bb0390","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1200\/JCO.23.02547","article-title":"Clonal hematopoiesis and therapy-related myeloid neoplasms after autologous transplant for Hodgkin lymphoma","volume":"42","author":"Yan","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0395","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/bjh.15757","article-title":"Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma","volume":"185","author":"Paczkowska","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0400","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nm.2129","article-title":"Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma","volume":"16","author":"Lamprecht","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0405","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2015.127498","article-title":"Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis","volume":"100","author":"Wein","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0410","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein\u2013Barr viral genomes in Reed\u2013Sternberg cells of Hodgkin\u2019s disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0415","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0420","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein\u2013Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2024.10.004_bb0425","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0430","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","article-title":"Latent membrane protein 1 of Epstein\u2013Barr virus mimics a constitutively active receptor molecule","volume":"16","author":"Gires","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.10.004_bb0435","first-page":"549","article-title":"The Epstein\u2013Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-\u03ba B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain","volume":"10","author":"Huen","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2024.10.004_bb0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0960-9822(93)90196-U","article-title":"Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein\u2013Barr virus and the bovine leukemia virus","volume":"3","author":"Alber","year":"1993","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0445","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein\u2013Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0450","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","article-title":"Rewiring of B cell receptor signaling by Epstein\u2013Barr virus LMP2A","volume":"117","author":"Fish","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.10.004_bb0455","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0460","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin and Reed\/Sternberg cells in Hodgkin\u2019s lymphoma","volume":"118","author":"Br\u00e4uninger","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0465","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ijc.24502","article-title":"Mutations of NFKBIA, encoding I\u03baB\u03b1, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases","volume":"125","author":"Lake","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0470","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.3390\/cancers13153909","article-title":"MicroRNA and other non-coding RNAs in Epstein\u2013Barr virus-associated cancers","volume":"13","author":"Notarte","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2024.10.004_bb0475","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.85","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"van der Weyden","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.molmed.2024.10.004_bb0480","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed\u2013Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0485","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing primary Hodgkin and Reed\u2013Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0490","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1084\/jem.189.12.1939","article-title":"Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed\u2013Sternberg cells","volume":"189","author":"Kapp","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0495","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1182\/blood-2008-01-134783","article-title":"Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3\u03b1","volume":"112","author":"Lamprecht","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0500","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood-2007-08-105643","article-title":"IL-21 is expressed in Hodgkin lymphoma and activates STAT5; evidence that activated STAT5 is required for Hodgkin lymphomagenesis","volume":"111","author":"Scheeren","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0505","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/leu.2014.345","article-title":"The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells","volume":"29","author":"Ullrich","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0510","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.24389","article-title":"Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed\u2013Sternberg cells: involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin\u2019s lymphoma","volume":"125","author":"Cattaruzza","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0515","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2016.05.001","article-title":"NF-\u03baB deregulation in Hodgkin lymphoma","volume":"39","author":"Weniger","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0520","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V98.9.2784","article-title":"Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines","volume":"98","author":"Fiumara","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0525","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/leu.2017.275","article-title":"S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells","volume":"32","author":"Vrzalikova","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0530","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2005.05881.x","article-title":"Inhibition of the phosphatidylinositol-3 kinase\/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma","volume":"132","author":"Georgakis","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0535","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2013-04-499004","article-title":"The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1","volume":"122","author":"Cader","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0540","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.leukres.2007.05.019","article-title":"Autocrine NGF\u03b2\/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines","volume":"32","author":"Renn\u00e9","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0545","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","article-title":"Autocrine and paracrine activated receptor tyrosine kinases in classical Hodgkin lymphoma","volume":"105","author":"Renn\u00e9","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0550","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V97.4.1063","article-title":"Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease","volume":"97","author":"Teofili","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0555","first-page":"126","article-title":"Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin\u2019s disease","volume":"6","author":"Moreau","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0560","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0565","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/leu.2008.101","article-title":"Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma","volume":"22","author":"Jundt","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0570","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/leu.2017.203","article-title":"An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma","volume":"32","author":"Lollies","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0575","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1093\/emboj\/cdf389","article-title":"Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-\u03ba B","volume":"21","author":"Mathas","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2024.10.004_bb0580","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molmed.2024.10.004_bb0585","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0590","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","article-title":"Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells","volume":"122","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0595","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2006-04-015164","article-title":"Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0600","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1189\/jlb.3MR0315-136R","article-title":"The role of T cells in the microenvironment of Hodgkin lymphoma","volume":"99","author":"Wein","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0610","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V92.7.2252","article-title":"Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin\u2019s disease tumor cells","volume":"92","author":"Bosshart","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0615","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","article-title":"Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL","volume":"109","author":"Chiu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.11370","article-title":"Expression of CCL5\/RANTES by Hodgkin and Reed\u2013Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue","volume":"107","author":"Fischer","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0625","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.4306","article-title":"Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin\u2019s lymphoma","volume":"232","author":"Hansen","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0630","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","article-title":"Complex immune evasion strategies in classical Hodgkin lymphoma","volume":"5","author":"Wein","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0635","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.V82.4.1247.1247","article-title":"Hodgkin\u2019s lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice","volume":"82","author":"Kapp","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0640","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0645","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V87.9.3844.bloodjournal8793844","article-title":"Analysis of major histocompatibility complex class I expression on Reed\u2013Sternberg cells in relation to the cytotoxic T-cell response in Epstein\u2013Barr virus-positive and -negative Hodgkin\u2019s disease","volume":"87","author":"Oudejans","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0650","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fimmu.2018.00267","article-title":"Acquired natural killer cell dysfunction in the tumor microenvironment of classic Hodgkin lymphoma","volume":"9","author":"Chiu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0655","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0660","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/labinvest.2008.24","article-title":"The CD4+CD26- T-cell population in classical Hodgkin\u2019s lymphoma displays a distinctive regulatory T-cell profile","volume":"88","author":"Ma","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.molmed.2024.10.004_bb0665","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1\u2013PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0670","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2016-02-700773","article-title":"Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma","volume":"129","author":"Du","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0675","doi-asserted-by":"crossref","first-page":"36854","DOI":"10.18632\/oncotarget.9210","article-title":"Repression of TCF3\/E2A contributes to Hodgkin lymphomagenesis","volume":"7","author":"Guan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2024.10.004_bb0680","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2012-05-431429","article-title":"PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells","volume":"121","author":"Yuki","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0685","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"K\u00fcppers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0690","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood.V97.3.818","article-title":"Evidence that Hodgkin and Reed\u2013Sternberg cells in Hodgkin disease do not represent cell fusions","volume":"97","author":"K\u00fcppers","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0695","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.1073\/pnas.1312509110","article-title":"Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed\u2013Sternberg cells","volume":"110","author":"Rengstl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.10.004_bb0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124629","article-title":"Reed\u2013Sternberg cells form by abscission failure in the presence of functional Aurora B kinase","volume":"10","author":"Xavier de Carvalho","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.10.004_bb0705","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0710","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/leu.2015.328","article-title":"Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma","volume":"30","author":"Hartmann","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2024.10.004_bb0715","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/s41467-020-16375-6","article-title":"Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"11","author":"Thurner","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.10.004_bb0720","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3324\/haematol.2023.282698","article-title":"B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"108","author":"Thurner","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0725","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0730","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood.V87.8.3418.bloodjournal8783418","article-title":"Peripheral blood mononuclear cells of a patient with advanced Hodgkin\u2019s lymphoma give rise to permanently growing Hodgkin\u2013Reed Sternberg cells","volume":"87","author":"Wolf","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0735","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000112062","article-title":"U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma","volume":"119","author":"Mader","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.molmed.2024.10.004_bb0740","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/hsz-2017-0321","article-title":"Hodgkin lymphoma cell lines: to separate the wheat from the chaff","volume":"399","author":"Drexler","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.molmed.2024.10.004_bb0745","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-2141.2002.03894.x","article-title":"An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein\u2013Barr virus-positive Hodgkin\u2019s lymphoma-derived cell line L591","volume":"119","author":"Vockerodt","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0750","first-page":"596","article-title":"Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin\u2019s lymphoma","volume":"91","author":"Willenbrock","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0755","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood.V87.8.3429.bloodjournal8783429","article-title":"Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin\/Reed\u2013Sternberg cells of a Hodgkin\u2019s lymphoma patient","volume":"87","author":"Kanzler","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0760","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2009.010157","article-title":"Mutations in the genes coding for the NF-\u03baB regulating factors I\u03baB\u03b1 and A20 are uncommon in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma","volume":"95","author":"Schumacher","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2024.10.004_bb0765","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ijc.10399","article-title":"Common and differential chemokine expression patterns in RS cells of NLP, EBV positive and negative classical Hodgkin lymphomas","volume":"99","author":"Maggio","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molmed.2024.10.004_bb0770","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0775","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.004_bb0780","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0785","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0790","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","article-title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK\u2013STAT signaling activation","volume":"131","author":"Vigano","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0795","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0800","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0805","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","article-title":"Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma","volume":"128","author":"Mansouri","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0810","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V98.9.2762","article-title":"Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma","volume":"98","author":"Leith\u00e4user","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2024.10.004_bb0815","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"K\u00fcppers","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2024.10.004_bb0820","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/sj.leu.2403841","article-title":"Insight into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas","volume":"19","author":"Schmitz","year":"2005","journal-title":"Leukemia"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:18:46Z","timestamp":1762546726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":164,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1471491424002715"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.10.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Hodgkin lymphoma research","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}